Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Shares Up 7.7 Percent on New USPS Instrument Placements

NEW YORK, Jan. 25 (GenomeWeb News) - Shares in Cepheid were up 7.71 percent, or $.68, at $9.50 in late-afternoon trading after the company said it received an order from the US Postal Service for 300 additional anthrax-detection modules.

The news also caused Pacific Growth Equities today to upgrade Cepheid stock to "overweight" from "equal weight."

 

As GenomeWeb News reported this morning, Cepheid said the USPS will use the instruments, which are based on the firm's GeneXpert PCR technology, at mail processing centers in the United States.

 

The USPS will use them with Biohazard Detection Systems developed by  Northrop Grumman's Security Systems to detect biological threats for the USPS. The new order is part of the second phase of the project, with modules being installed starting in April. At present, the company is shipping and installing 800 GeneXpert modules that were ordered for the first phase of the project.

 

Cepheid expects an additional order of 300 modules later this year. In total, detection systems are planned for 283 mail processing centers throughout the US.

 

Pacific Growth Equities said it now expects Cepheid to post $71.9 million in first-quarter revenue. It had originally expected the company to generate $61.9 million in revenue.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.